Lynch syndrome awareness day

Lynch syndrome. Even though it is the most common hereditary cancer syndrome in the world, it is mostly unknown. Lynch syndrome prevalence is currently estimated at 1 in 279 globally[1], meaning that in Europe alone

... read more

Announcement – CSO Appointment

We are excited to announce that Minttu Kansikas has been appointed as Chief Scientific Officer to lead the research efforts and laboratory functions. Congratulations! Minttu is a co-inventor and one of the leading scientists behind

... read more

Welcome to our updated Website

Welcome! We have updated our website and hope you enjoy the new structure and features! This new section being one of them, and the twitter feed, being another. And there are many more to come!

... read more

LS CancerDiag joins InvestHorizon Accelerator

LS CancerDiag joins the InvestHorizon Accelerator, we are delighted to have been accepted to the programme! InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding. The selected deep tech companies

... read more

Proud to see our current member @lscancerdiag and a bunch of our alumni startups and corporate partners featured in the digital booklet showcasing world-class diagnostic innovations from Finland!🙌


Trending #startups in August:
@BCasterltd, iFarm, @CanitApp, @Made_of_Sundays, @lscancerdiag, @Pikasiirto, @immersal_ar, @MrAutofire, @LogmoreLtd, @combinostics.

Check out the full list at 🔥

🩺Did you know that 40% of cancer cases are preventable?

📝@EU_Commission's #BeatingCancerPlan aims to protect people from avoidable cancers, improve access to screening & early diagnosis

👉 #EUCancerPlan #MissionCancer

Congratulations to our Six Scandinavian start-ups ready for EIT Health Catapult Semifinals @eithealth @cardiolyse @lscancerdiag @KamuHealth @Finnadvance

Load More...